Sub-Q Bionics, Inc
Medtech startup developing an implantable, intelligent bionic pump to mechanically assist lymphatic drainage for patients with lymphedema, with a focus on women affected by cancer treatments. The company pursues academic collaborations, licensing, and investor funding to advance preclinical and clinical development.
Industries
Nr. of Employees
small (1-50)
Sub-Q Bionics, Inc
Products
Implantable lymphatic drainage system (prototype)
An implantable bionic pump system designed to mechanically assist lymphatic circulation in patients with lymphedema, intended to reduce swelling, pain, and dependency on external compression.
Implantable lymphatic drainage system (prototype)
An implantable bionic pump system designed to mechanically assist lymphatic circulation in patients with lymphedema, intended to reduce swelling, pain, and dependency on external compression.
Services
Collaborative research, licensing, and clinical engagement with academic medical centers and clinical specialists to advance device development.
Fundraising, investor presentations, and participation in medtech conferences to secure capital and commercial partners.
Collaborative research, licensing, and clinical engagement with academic medical centers and clinical specialists to advance device development.
Fundraising, investor presentations, and participation in medtech conferences to secure capital and commercial partners.
Expertise Areas
- Implantable medical device development
- Lymphedema therapy and management
- Surgical collaboration and clinical evaluation
- Academic partnerships and licensing
Key Technologies
- Implantable active pump systems
- Embedded control and intelligent implant electronics
- Surgical implantable device design
- Digital health / mHealth engagement (remote monitoring and networking)
News & Updates
Company presentation and pitching at the Medtech MVP conference (investor pitch contest).
Participation and networking at mHealth Tokyo and Japan Health Conference to engage investors and advisors.
Participation in MedTech World Middle East to connect with medtech investors and partners.
Announcement of a $1.5M pre-seed round including investment from institutional and private investors with matching funds from a national innovation authority.
Announcement of a licensing agreement with a major academic medical center to advance the implantable lymphatic drainage system.
Company presentation and pitching at the Medtech MVP conference (investor pitch contest).
Participation and networking at mHealth Tokyo and Japan Health Conference to engage investors and advisors.
Participation in MedTech World Middle East to connect with medtech investors and partners.
Announcement of a $1.5M pre-seed round including investment from institutional and private investors with matching funds from a national innovation authority.
Announcement of a licensing agreement with a major academic medical center to advance the implantable lymphatic drainage system.